Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$71.58 - $87.29 $1.31 Million - $1.6 Million
18,349 Added 19.46%
112,617 $8.25 Million
Q4 2023

Jan 23, 2024

BUY
$73.27 - $83.09 $5.22 Million - $5.92 Million
71,195 Added 308.56%
94,268 $7.64 Million
Q3 2023

Nov 02, 2023

BUY
$73.94 - $80.67 $1.71 Million - $1.86 Million
23,073 New
23,073 $1.73 Million
Q1 2023

May 05, 2023

BUY
$77.31 - $88.08 $5.63 Million - $6.42 Million
72,860 Added 68.12%
179,813 $14.9 Million
Q4 2022

Jan 25, 2023

SELL
$62.32 - $89.47 $2.23 Million - $3.21 Million
-35,852 Reduced 25.11%
106,953 $0
Q3 2022

Oct 26, 2022

BUY
$59.54 - $68.01 $8.05 Million - $9.2 Million
135,277 Added 1796.98%
142,805 $8.81 Million
Q2 2022

Aug 02, 2022

BUY
$57.72 - $65.01 $135,872 - $153,033
2,354 Added 45.5%
7,528 $465,000
Q1 2022

May 10, 2022

SELL
$57.92 - $72.58 $1.84 Million - $2.31 Million
-31,824 Reduced 86.02%
5,174 $307,000
Q4 2021

Jan 31, 2022

BUY
$64.88 - $73.64 $2.09 Million - $2.37 Million
32,225 Added 675.15%
36,998 $2.69 Million
Q3 2021

Nov 15, 2021

SELL
$67.69 - $73.03 $56,791 - $61,272
-839 Reduced 14.95%
4,773 $333,000
Q2 2021

Aug 13, 2021

BUY
$63.47 - $69.35 $42,588 - $46,533
671 Added 13.58%
5,612 $386,000
Q1 2021

May 18, 2021

SELL
$60.0 - $68.46 $1.35 Million - $1.54 Million
-22,454 Reduced 81.96%
4,941 $319,000
Q4 2020

Feb 04, 2021

SELL
$56.65 - $64.55 $3.26 Million - $3.71 Million
-57,552 Reduced 67.75%
27,395 $1.6 Million
Q3 2020

Oct 26, 2020

BUY
$62.1 - $78.08 $198,347 - $249,387
3,194 Added 3.91%
84,947 $5.37 Million
Q2 2020

Jul 21, 2020

BUY
$72.34 - $84.0 $5.45 Million - $6.32 Million
75,285 Added 1163.96%
81,753 $6.29 Million
Q1 2020

Apr 16, 2020

SELL
$62.63 - $80.22 $1.69 Million - $2.16 Million
-26,948 Reduced 80.64%
6,468 $484,000
Q4 2019

Feb 06, 2020

BUY
$61.62 - $67.78 $2.06 Million - $2.26 Million
33,416 New
33,416 $2.17 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Steel Peak Wealth Management LLC Portfolio

Follow Steel Peak Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steel Peak Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steel Peak Wealth Management LLC with notifications on news.